BMS forms immuno-oncology collaboration with 10 US and EU cancer institutes

Bristol-Myers Squibb (BMS) formed the International Immuno-Oncology Network (II-ON) with 10 research centers in the US and EU as a global collaboration between industry and academia to broaden global scientific understanding of how the body's immune system can be harnessed to fight cancer.